Cenofex Innovations awarded $1.5M from NSW Medical Devices Fund

 Left to right: Dr. Sheridan Gho, Dr. Michael Weaver and Mr. Tri Luong of Cenofex Innovations with the NSW Medical Devices Fund Award 2018 at NSW Parliament House.

Left to right: Dr. Sheridan Gho, Dr. Michael Weaver and Mr. Tri Luong of Cenofex Innovations with the NSW Medical Devices Fund Award 2018 at NSW Parliament House.

Cenofex Innovations has been awarded a $1.5M investment from the NSW 2018 Medical Devices Fund.

The NSW Medical Devices Fund is a competitive technology development and commercialisation program that aims to provide support to take local innovation to market. The fund is unique in its approach to provide substantial early funding support for technologies that are capable of improving patient care or health well-being and generating economic, social or environmental benefits to the state of NSW.

Cenofex Innovations was one of seven successful companies announced in the 2018 round, and one of three located in Wollongong (Hello medtech-innovation-hub!) The funds will accelerate our product development and enable us to complete early clinical trials. Most importantly, the funds will help Cenofex Innovations bring to market a medical device that will transform the treatment of lymphoedema.

For Cenofex Innovations, receiving these funds, following our successful NSW Health Rosenman Institute Fellowship, is particularly rewarding as it demonstrates faith in our causes and capability, and validates the work we conducted at that time.

We are delighted with this outcome, and look forward to delivering even bigger and better things with this support.

The 2018 Medical Devices Fund recipients discussing their projects and the fund.

Cenofex cleans up at 2018 MDCTP Awards Night

Cenofex Innovations proved to be very successful at the 2018 Medical Device Commercialisation Training Program (MDCTP) Awards Night, sweeping up both the Davies Collison Cave Intellectual Property and the Brandwood Biomedical Regulatory Award.

Supported by Cicada Innovations and NSW Health, and presented by the NSW Minister of Health, the awards provide valuable in-kind services from two highly experienced firms and are available to graduates of the MDCTP.

Since the awards, we have been delighted to work with William Hird to file our Australian Provisional Patent, and Arthur Brandwood to develop our Regulatory Review and Strategy. Beyond the monetary value of the awards, having such experienced and accessible experts working on these important pieces of our overall strategy has been of huge benefit to Cenofex Innovations. Thank you for the continued support, Cicada Innovations and NSW Health!

Cenofex Innovations founders, Dr Michael Weaver and Dr Sheridan Gho, with Arthur Brandwood of Brandwood Biomedical (far left) and the Hon. Brad Hazzard, NSW Minister of Health (far right).

 Cenofex Innovations founders, Dr Michael Weaver and Dr Sheridan Gho, with William Hird of  Davies Collison Cave  (far left) and the Hon. Brad Hazzard, NSW Minister of Health (far right).

Cenofex Innovations founders, Dr Michael Weaver and Dr Sheridan Gho, with William Hird of Davies Collison Cave (far left) and the Hon. Brad Hazzard, NSW Minister of Health (far right).

Back Down Under and Racing Ahead

AdobeStock_96081635.jpeg

It has been a while since I updated this blog! Things have been extremely busy and time has flown by. So here's a very quick summary.

We are delighted that Tri has continued with Cenofex Innovations as the Head of Business and Finance. We appreciate all the experience he brings to the team, and his personality and attitude are a great fit for Cenofex.

We wrapped up our NSW Health-Rosenman Institute Fellowships in San Francisco in November, 2017. It was a fantastic experience, we learnt a great deal and developed lasting networks, and are excited about returning to NSW with that knowledge and experience.

We founded Cenofex Innovations Pty Ltd in NSW, Australia and look forward to growing our Australian medical device company. We are now working closely with medical device development experts, ide Group in Sydney to complete our proof of concept and move into product development.

I look forward to updating this site with more information regarding our device, and on-going work once we have secured our IP position and locked down our product design. Until then, it's probably going to have to stay a bit under wraps for now...

Cheers!
Sheridan

 

Supporting sporting success

Cenofex Innovations believes in community involvement, and empowering women, and what better way to show this than supporting a local women's rugby team?

This month we were proud to partner in sponsorship with the San Francisco Golden Gate Women's Rugby Club. Rugby is a great sport that celebrates all the things we believe a medical device start-up should strive for - excellence, teamwork, commitment, hard work, diversity and fun! 

Thanks for the shout out too! 

#GoGate

POST UPDATE: The SFGG Women made it all the way to the Division II National Championships! Congratulations team!

 

Inventions, verification, and validation

Over the last couple of months, Cenofex Innovations has grown as a team (welcome Jacob and Tri!), worked with the Startup Legal Garage team to produce a FTO search, networked with key innovation, accelerator, and clinical groups, and met many amazing people. Like any medical device start-up, the number of things that need to be juggled can be dizzying at times.

However, the bulk of our energy has been, rightfully so, channeled towards the development of our device. Having, what we think, is a brilliant idea, and following through with building it, has been quite the journey already. After this initial development phase comes verification and validation, and with a novel device, such as ours, designing accurate verification tools poses interesting challenges along the way.

To this end, our focus over the past few months has very much been designing, developing, and building the right tools to ensure our device is delivering the treatment we expect it to. Michael has been deep in the research and development of a verification tool, capable of measuring pressures in three-dimensional volumes. He's been doing everything from coding GUIs and designing circuitry, to fabricating support structures and interfacing motors. In the meantime, Sheridan and Jacob have been working on the development of a lymphoedema phantom - a model with human tissue equivalent properties, that represents the lymphatic system, in order to enable the "bench-top" validation of our technology.

Both these projects will provide tools essential for the verification and validation of our device and are an important step on the way to getting safe treatment to those who need it.